Highly potent and specific siRNAs against E6 or E7 genes of HPV16- or HPV18-infected cervical cancers
Open Access
- 1 October 2010
- journal article
- Published by Springer Science and Business Media LLC in Cancer Gene Therapy
- Vol. 17 (12), 827-836
- https://doi.org/10.1038/cgt.2010.38
Abstract
Infection with high-risk types (type 16 or type 18) of human papillomaviruses (HPVs) increases a patient's risk of cervical cancer. Given the importance of the cervix and the severe side effects resulting from traditional cancer therapies, this study aimed to achieve targeted inhibition of viral oncogenes in tumor cells using small interfering RNAs (siRNA). To accomplish this, we developed nine siRNAs against either the E6 or E7 genes of HPV-16 or HPV-18 in several combinations, yielding siRNAs targeting 16E6, 16E7, 18E6 and 18E7. We measured the effectiveness of the siRNAs by examining E6 or E7 mRNA expression after transfection of the siRNAs into HPV-positive CaSki (HPV-16) or HeLa (HPV-18) cell lines. We found that the HPV-siRNAs significantly reduced cell growth and colony formation in both cell lines. Flow cytometry analysis revealed a significant increase in apoptosis. The siRNAs had no effect on cell growth, colony formation or apoptosis in HPV-negative C33A cells, demonstrating a lack of off-target effects. In addition, an in vivo xenograft study showed that intra-tumoral injection of the siRNAs reduced tumor growth in BALB/c nude mice. In conclusion, we have developed highly specific and potent HPV-siRNAs that successfully suppress tumor growth and induce apoptosis in HPV-positive cervical cancer cells. siRNA treatment has potential for further development as an adjuvant therapy for cervical cancer.Keywords
This publication has 23 references indexed in Scilit:
- New highly potent and specific E6 and E7 siRNAs for treatment of HPV16 positive cervical cancerCancer Gene Therapy, 2007
- Differentially expressed genes in radioresistant nasopharyngeal cancer cells: gp96 and GDF15Molecular Cancer Therapeutics, 2007
- Strategies for silencing human disease using RNA interferenceNature Reviews Genetics, 2007
- Increasing Blunting of Inhibin Responses to Dynamic Ovarian Challenge Is Associated With Reproductive Aging in the RatReproductive Sciences, 2007
- Silencing of HPV 18 Oncoproteins With RNA Interference Causes Growth Inhibition of Cervical Cancer CellsReproductive Sciences, 2007
- The E7 Oncoprotein Is Translated from Spliced E6*I Transcripts in High-Risk Human Papillomavirus Type 16- or Type 18-Positive Cervical Cancer Cell Lines via Translation ReinitiationJournal of Virology, 2006
- HPV‐mediated cervical carcinogenesis: concepts and clinical implicationsThe Journal of Pathology, 2005
- RNA-directed transcriptional gene silencing in mammalsTrends in Genetics, 2005
- Mechanisms of Human Papillomavirus-Induced OncogenesisJournal of Virology, 2004
- Human papillomaviruses: targeting differentiating epithelial cells for malignant transformationOncogene, 2003